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20-O-(3-(Furan-2-yl)propyl)adenosine was synthesized and
evaluated for interstrand crosslink (ICL) formation in DNA
duplexes. In situ oxidation of the furan moiety with NIS showed
rapid crosslink formation to dA and dC, while dT and dG were
inactive.
Oligonucleotides that form interstrand crosslinks (ICLs) have
found widespread applications in chemical biology research
areas. Therefore, chemical and enzymatic methods have been
developed to incorporate crosslinks into helical regions of
DNA and RNA.1 Examples include the synthesis of a duplex
incorporating a preformed crosslinked dinucleotide2,3 or post-
synthetic modiﬁcation of duplexes by bifunctional crosslinking
reagents.4,5 However, in some cases, the site-speciﬁc introduction
of a crosslink is problematic due to formation of a mixture
of monoadducts, intrastrand and interstrand crosslinks.
Introduction of reactive moieties at a speciﬁc position within
the duplex can circumvent the selectivity issue as is shown for
photocrosslinking with 4-thiouridine,6 5-bromouridine,7
5-methyleneaminouridine8 or 8-azidoadenosine.9 Furthermore,
a thio-modiﬁed oligonucleotide (ON) can form disulﬁde bonds
post-synthetically.10,11 However such ICLs are highly dependent
on the proper positioning of thiol groups and, more impor-
tantly, require modiﬁcation of both strands. More recent
studies on site-speciﬁc ICL formation involve modiﬁed phenyl-
selenyl derivatives of thymidine or 5-methyl-20-deoxycytidine,12
1,4-dioxobutane abasic lesion,13 alkyl-connected 2-amino-
6-vinylpurine14 and 4-amino-6-oxo-2-vinylpyrimidine.15 We
have earlier developed a complementary methodology incorpo-
rating furan-modiﬁed 20-amido-uridine and an acyclic building
block to give a site-speciﬁc ICL upon oxidation with N-
bromosuccinimide (NBS).16,17
First crosslinking results obtained for the furan-modiﬁed
20-amido-uridine with complementary adenine (A) were further
extended into a more detailed selectivity study against all
canonicals using a more synthetically accessible acyclic furan-
modiﬁed building block. In the latter case, strong selectivity
for crosslinking to its opposite canonical A or cytidine (C) was
observed, without formation of crosslinks to neighboring or
distant bases.17
In this context, furan-modiﬁcation on other canonicals than
uridine and the potential impact on the crosslinking process
have not been evaluated yet. From this point of view, we
became interested in evaluating the scope of furan-modiﬁed
purines for ICL. We here wish to report on the synthesis and
incorporation of 20-O-(3-(furan-2-yl)propyl)adenosine as a
building block for crosslinking of DNA duplexes.
From a synthetic point of view, 20-modiﬁcation was an
obvious choice as nucleobase modiﬁcation will in most cases
be unfavourable for hybridization. Taking into account that
2,20-anhydrointermediates are only feasible for pyrimidines,
a 20-amido modiﬁcation of adenosine is diﬃcult to achieve.
Therefore, we decided to take advantage of our previously
developed 20-O-alkylation strategy of adenosine.18 Moreover,
linkage of a furan moiety via an ether instead of an amide
connection has the additional advantage of more conforma-
tional ﬂexibility.
Following our earlier protocol, without requiring protection,
the adenosine 20-OH was selectively propargylated (Scheme 1)
to give nucleoside 2 in 45% yield. Next, the exocyclic amine
was benzoylated (2 - 3), followed by microwave-assisted
Sonogashira coupling with 2-iodofuran19 to aﬀord compound 4.
Upon subsequent hydrogenation, the desired 3-(furan-2-yl)-
propyl derivative 5 was obtained in excellent yield. Further
conversion into the corresponding 50-O-DMT-30-O-phospho-
ramidite 7 was carried out using standard methodology and
proceeded without incidence.18
Having the phosphoramidite 7 at hand, four ON sequences
were synthesized (Fig. 1) with the furanyl compound in
between two identical canonicals. Sequences 8–11 were obtained
uneventfully in high purity (99%) after Sep-pak cartridge
puriﬁcation, which indicated the smooth incorporation of
phosphoramidite 7.
Subsequently, each individual sequence 8–11 was subjected
to hybridization experiments with a total of four complementary
sequences, by varying only the base opposite to our modiﬁed
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adenosine A*. It was interesting to ﬁnd that incorporation of
A* led to destabilization (1.6–9.6 1C) in most cases, with
exception of a stabilizing eﬀect, i.e. 1.7 1C or 5.1 1C, for the
hybrids of sequence 11 with the complementary sequence
having A or C opposite to A*, respectively (Table S1, ESIw).
The increase in duplex stability can possibly be attributed to the
stacking interactions between the neighbouring nucleotides20
and the ﬂexible 20-O-alkyl substitution so as to accommodate
well in the major groove.
Next, the potential of the furan-modiﬁed building block for
crosslinking was evaluated. Crosslinking reactions were performed
at 25 1C at 0.02 mM concentration in 10 mM phosphate buﬀer at
pH 7, containing 100 mM NaCl. For this purpose, ﬁrst duplex
d(CTGACGCA*CTGC) (8)30-d(GACTGCGAGACG) (12)
(1 nmole) was dissolved in 0.1 M phosphate buﬀer (5 mL) and
1 M NaCl (5 mL) and the total volume adjusted to 50 mL with
millipore water. The solution was treated with a freshly prepared
solution of NBS or N-iodosuccinimide (NIS) in millipore water
and crosslink formation was monitored by RP-HPLC (Fig. 2).
Upon addition of two equivalents of NBS, partial conver-
sion of the non-crosslinked duplex (panel C) into a new species
was noticed after 30 minutes (panel D). The expected cross-
linked character of the major species was conﬁrmed by gel
electrophoresis and mass spectrometric analysis (vide infra and
data in ESIw). Despite the promising outcome of the crosslink
experiment, we anticipated that NIS could give faster ICL
formation and consequently the eﬀectivity of NBS and NIS
was compared for duplex (8)(12). It was observed that on
average up to six equivalents of NBS are required for complete
consumption of the furan-modiﬁed strand (ESIw). In contrast,
generally four equivalents of NIS suﬃced for complete con-
version, thereby clearly outperforming NBS.
Therefore, NIS became the oxidant of choice to complete a
series of crosslinking reactions evaluating (8) to (11) against
complements with a varying opposite base. It was observed
that in all duplexes featuring A or C as an opposite partner, a
crosslink peak appeared. In contrast, opposite to T or G, no
crosslink was formed and modiﬁed ONs were completely
degraded to a mixture of products (ESIw). As crosslinked
products in all cases show similar retention times as the original
furan-modiﬁed strands, the degradation of a non-crosslinked
furan-modiﬁed strand renders puriﬁcation of the crosslinked
material facile, leading to isolation of pure crosslinked duplexes
in yields of 15–25%. In all cases, the crosslink peaks for A*
opposite to A showed higher intensity on HPLC than opposite
to C. Crosslinking experiments were also analyzed by denaturing
PAGE. Fig. 3 shows slower-migrating crosslinked species
(as conﬁrmed by ESI-MS analysis) when A and C are opposite
partners in a duplex with oligonucleotide 8.
As described earlier for cis-2-butene-1,4-dial, crosslinked
adducts are formed after initial attack of an exocyclic amine
on a cis-2-buten-4-oxo-1-al (Fig. 3, right), followed byMichael
addition, resulting in bi- (in case of C) or tricyclic (in case of A)
Scheme 1 Reagents and conditions: (i) NaH, TBAI, CHCCH2Br,
DMF, 55 1C, 2 d (45%); (ii) TMSCl, BzCl, C5H5N, 0 1C, 6 h (92%);
(iii) 2-iodofuran, Pd(PPh3)2Cl2, CuI, Et3N/DMF, mwave, 55 1C, 30 min
(95%); (iv) H2/Pd–C, 20 bar, 30 1C, 15 min (93%); (v) DMTrCl,
C5H5N, rt, 16 h (77%); (vi) NC(CH2)2OP(NiPr2)Cl, DIPEA, CH2Cl2,
rt, 3 h (92%).
Fig. 1 Synthetic oligonucleotides with A* as the modiﬁed adenosine. Fig. 2 RP-HPLC analysis of crosslink reactions with NBS and
NIS: (A and B) 8 and 12 before and after NIS addition respectively;
(C) 8 : 12 before NBS/NIS addition, t = t0; (D and E) 8 : 12 after
2 equiv. of NBS and NIS respectively, t= t0 + 30 min; (F) 8 : 12 after
4 equiv. of NIS, t = t0 + 60 min. All ODN sequences are mixed in a
1 : 1 ratio to obtain a 20 mM ﬁnal duplex concentration.
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structures.17,21 Considering duplex stability, internal incorpo-
ration of the 20-O-(3-propyl)-furan modiﬁed nucleoside leads
to more stable duplexes than internal incorporation of the
furan-modiﬁed 20-amido-uridine in similar sequences (DTm varying
between 3.6 and 19.9 1C).22 The most stable duplexes are
formed when A* is incorporated in between two guanosines
(11) and placed opposite to A or C. This increase in stability
does not aﬀect A or C crosslinking selectivity, therefore
excluding the possibility of correlation between duplex stability
and selectivity in ICL formation.
In conclusion, we have developed a straightforward synthesis
of a 20-O-furanylpropyl adenosine building block. Incorpora-
tion into double-stranded DNA reduced duplex stability loss
in comparison with the previously reported 20-amido-uridine
and acyclic furan-modiﬁed building blocks. Incorporation
within a G(A*)G/CCC context even leads to a >5 1C stabili-
sation of the 12-mer duplex. The current investigation further
identiﬁed NIS as a superior oxidant over NBS in terms of
stoichiometry for the crosslinking reaction.
The selectivity of this new furan-modiﬁed purine derivative
in furan-oxidation crosslinking was evaluated to show preferential
reaction with A and C (with a surprising slight preference for
crosslinking to A). Though in this speciﬁc case, yields are
not the highest, a combination of features renders the furan-
oxidation crosslink methodology very attractive. Beneﬁtting
from an induced reactivity principle and proximity being a
prerequisite for crosslinking, we have demonstrated that only
equimolar amounts of modiﬁed strands are necessary to
produce substantial amounts of crosslinked material without
collateral damage or undesired side reactions. Formation of
stable crosslinked duplexes is fast and puriﬁcation is facile in
view of the ‘self-destructing’ behaviour of the furan-modiﬁed
strands. As illustrated by current and previous work,16,17,22
construction of the furan modiﬁed nucleoside building blocks
beneﬁts from the commercial availability of a broad range of
furan derivatives and follows a very modular and straight-
forward synthetic route. There is no need for orthogonal
protective group manipulations as the furan moiety is
completely stable to conditions for phosphoramidite and
oligonucleotide synthesis. Fine-tuning of duplex stability,
crosslink selectivity and yield is thus possible depending on
the speciﬁc choice of the building block and desired target.
From current and previous studies on furan modiﬁcation, it
appears plausible to use a 20-amido-linker for pyrimidine
nucleoside and a 20-O-alkyl-linker for purine nucleoside
modiﬁcation. As such, in view of its synthetic accessibility,
its complementarity with the earlier developed furan-modiﬁed
uridine, its more beneﬁcial inﬂuence on duplex stability and its
observed crosslink selectivity, the here described 20-O-furanyl-
propyladenosine is a valuable addition to our recently developed
toolbox for furan-oxidation induced crosslinking.
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Fig. 3 ICL-formation of 8, analyzed by 20% denaturing PAGE,
with A* opposite to A, C, T and G in a duplex DNA (lanes 5–8). Far
right: structure of reactive ketoenal formed upon oxidation of a furan
moiety.
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